UBS Group »

Cardiol Therapeutics Inc- foreign shares owned by UBS Group

Quarter-by-quarter ownership of Cardiol Therapeutics Inc- foreign (CRDL) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Cardiol Therapeutics Inc- foreign

Tip: Access up to 7 years of quarterly data

All positions including Cardiol Therapeutics Inc- foreign held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cardiol Therapeutics Inc- foreign by UBS Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $4.8k 5.7k 0.84
2023-09-30 $2.3k 2.6k 0.90
2023-06-30 $2.2k 2.5k 0.89
2023-03-31 $10k 21k 0.49
2022-12-31 $5.6k 11k 0.51
2022-09-30 $2.0k 2.0k 1.00
2022-06-30 $7.0k 5.5k 1.27
2022-03-31 $13k 8.8k 1.48
2021-12-31 $10k 5.4k 1.86